{"ticker": {"uuid": "64f5ea0f-0a80-419b-ad28-3dae5980342c", "symbol": "BRVE", "name": "Braveheart Bio, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1mUVFYUEJLUXV0eVJFVVliOEtqRnUwdXFEcG1GRmk2M1NFYVdfVF9nZnNRVFh0TVBzUDNHcDZUY2JJZTB3Q09sNkhrQTlERUhVcmU3VFhn?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1mUVFYUEJLUXV0eVJFVVliOEtqRnUwdXFEcG1GRmk2M1NFYVdfVF9nZnNRVFh0TVBzUDNHcDZUY2JJZTB3Q09sNkhrQTlERUhVcmU3VFhn?oc=5", "source_link_is_lookup": false, "source_name": "Kalkine", "published_at": "2026-10-06T22:40:25+00:00", "published_display": "06 Oct 2026 22:40", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001978, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.4, "age_days": 9.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio (NASDAQ:BRVE) Stock Jumps 8.1% - Still a Buy?", "summary": "Braveheart Bio (NASDAQ: BRVE) shares rose 8.1% to $21.84, despite trading volume being 83% below average. Analysts generally have a positive outlook, with five \"Buy\" ratings and one \"Hold\" rating, and a consensus price target of $45.25. The company missed its quarterly earnings estimate significantly, reporting a loss of $2.51 per share against an estimated $0.25, but insiders have recently purchased a substantial amount of shares, totaling $157.5 million.", "url": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-stock-jumps-81-still-a-buy-2026-10-01", "source_link": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-stock-jumps-81-still-a-buy-2026-10-01", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-01T18:59:51", "published_display": "01 Oct 2026 18:59", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 69, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001026, "evidence_share": 100.0, "evidence_share_display": "100", "freshness_pct": 0.6, "age_days": 14.9, "influence_label": "Medium", "evidence_strength": 47, "duplicate_count": 2, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Braveheart Bio, Inc. (NASDAQ:BRVE) Shares Shorted: Short Interest Up 76.1% in September", "summary": "Braveheart Bio, Inc. (NASDAQ:BRVE) experienced a significant surge in short interest in September, increasing by 76.1% to 2.46 million shares. This represents 2.7% of shares outstanding and a days-to-cover ratio of 7.5 days. Despite a recent quarterly EPS miss, insiders have been actively purchasing shares, acquiring over 8.75 million shares worth approximately $157.5 million in the last 90 days, and analysts maintain a \"Moderate Buy\" rating with an average price target of $45.25.", "url": "https://www.marketbeat.com/instant-alerts/options-braveheart-bio-inc-nasdaq-brve-shares-shorted-short-interest-up-761-in-september-2026-09-29", "source_link": "https://www.marketbeat.com/instant-alerts/options-braveheart-bio-inc-nasdaq-brve-shares-shorted-short-interest-up-761-in-september-2026-09-29", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-29T17:25:03", "published_display": "29 Sep 2026 17:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00022, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.3, "age_days": 17.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "BRVE interactive stock chart | Braveheart Bio, Inc. stock", "summary": "This page provides an interactive stock chart for Braveheart Bio, Inc. (BRVE). The stock closed at $20.62, down 11.77%, and was trading at $21.08 in after-hours, up 2.21%. The chart allows users to select various time ranges and intervals to analyze the stock's performance.", "url": "https://uk.finance.yahoo.com/chart/BRVE", "source_link": "https://uk.finance.yahoo.com/chart/BRVE", "source_link_is_lookup": false, "source_name": "Market source", "published_at": "2026-09-25T10:51:06", "published_display": "25 Sep 2026 10:51", "source_kind": "aggregator", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 4.1e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 21.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio, Inc. (NASDAQ:BRVE) Receives Average Recommendation of \"Moderate Buy\" from Analysts", "summary": "Braveheart Bio, Inc. (NASDAQ:BRVE) has received an average \"Moderate Buy\" recommendation from analysts, with five out of six firms issuing a buy rating and an average 12-month price target of $45.25. Despite a significant earnings miss in the last quarter, insider buying has been substantial, with directors purchasing millions of shares totaling approximately $157.5 million. The company is a clinical-stage biopharmaceutical firm focused on therapies for hypertrophic cardiomyopathy, with its lead product candidate, BHB\u20111893, being developed for obstructive and non\u2011obstructive HCM.", "url": "https://www.marketbeat.com/instant-alerts/consensus-braveheart-bio-inc-nasdaq-brve-receives-average-recommendation-of-moderate-buy-from-analysts-2026-09-25", "source_link": "https://www.marketbeat.com/instant-alerts/consensus-braveheart-bio-inc-nasdaq-brve-receives-average-recommendation-of-moderate-buy-from-analysts-2026-09-25", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-25T09:54:30", "published_display": "25 Sep 2026 09:54", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 56, "tone_signals": ["Buy Rating"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000967, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.7, "age_days": 21.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio Inc (BRVE:UQ): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE56a09YenVKYUpqN1YtUTRFQ3JieVRaV0EyZXE1cmhvS1VYbzI2OU9DUUlCWXVYeG1fQk53cWRicTdNaXJ5WmljRE9EUWU3clFnb0lSMA?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE56a09YenVKYUpqN1YtUTRFQ3JieVRaV0EyZXE1cmhvS1VYbzI2OU9DUUlCWXVYeG1fQk53cWRicTdNaXJ5WmljRE9EUWU3clFnb0lSMA?oc=5", "source_link_is_lookup": false, "source_name": "bnnbloomberg.ca", "published_at": "2026-09-23T23:13:20+00:00", "published_display": "23 Sep 2026 23:13", "source_kind": "editorial_wire", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 3.8e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 22.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio (NASDAQ:BRVE) Hits New 52-Week Low - What's Next?", "summary": "Braveheart Bio (NASDAQ:BRVE) recently hit a new 52-week low of $24.17 after reporting significantly weaker-than-expected quarterly earnings. Despite the poor earnings performance, analysts maintain a \"Moderate Buy\" rating with an average price target of $45.25. Insider activity shows strong buying interest, with directors acquiring substantial shares in the last 90 days.", "url": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-hits-new-52-week-low-whats-next-2026-09-22", "source_link": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-hits-new-52-week-low-whats-next-2026-09-22", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-22T16:34:44", "published_display": "22 Sep 2026 16:34", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003023, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.6, "age_days": 24.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio (NASDAQ:BRVE) Trading Down 6.6% - Should You Sell?", "summary": "Braveheart Bio (NASDAQ:BRVE) shares dropped 6.6% to $27.26 on Monday, with trading volume significantly below average. Despite a substantial earnings miss, analysts maintain a \"Moderate Buy\" consensus with an average price target of $45.25. Insider buying totaling $157.5 million over the last three months suggests confidence in the company's future.", "url": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-trading-down-66-should-you-sell-2026-09-21", "source_link": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-trading-down-66-should-you-sell-2026-09-21", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-21T16:46:25", "published_display": "21 Sep 2026 16:46", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 44, "tone_signals": ["Negative market reaction", "Large negative market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.1e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 25.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio to Participate in Stifel Cardiometabolic Forum", "summary": "Braveheart Bio, Inc. announced its participation in the Stifel Virtual Cardiometabolic Forum on September 30, 2026. Management will host a fireside chat at 12:30 p.m. EDT, which can be accessed via a live webcast on their investor relations website. The company is a clinical-stage biopharmaceutical firm focusing on treatments for hypertrophic cardiomyopathy and other cardiovascular diseases, with its lead candidate BHB-1893 targeting obstructive and non-obstructive HCM.", "url": "https://www.manilatimes.net/2026/09/17/tmt-newswire/globenewswire/braveheart-bio-to-participate-in-stifel-cardiometabolic-forum/2427012", "source_link": "https://www.manilatimes.net/2026/09/17/tmt-newswire/globenewswire/braveheart-bio-to-participate-in-stifel-cardiometabolic-forum/2427012", "source_link_is_lookup": false, "source_name": "The Manila Times", "published_at": "2026-09-16T20:58:16", "published_display": "16 Sep 2026 20:58", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 29.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 3, "topics": ["Biopharmaceuticals", "Cardiovascular", "Clinical Trials", "Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}], "by_tier": {"direct": [{"title": "Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1mUVFYUEJLUXV0eVJFVVliOEtqRnUwdXFEcG1GRmk2M1NFYVdfVF9nZnNRVFh0TVBzUDNHcDZUY2JJZTB3Q09sNkhrQTlERUhVcmU3VFhn?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1mUVFYUEJLUXV0eVJFVVliOEtqRnUwdXFEcG1GRmk2M1NFYVdfVF9nZnNRVFh0TVBzUDNHcDZUY2JJZTB3Q09sNkhrQTlERUhVcmU3VFhn?oc=5", "source_link_is_lookup": false, "source_name": "Kalkine", "published_at": "2026-10-06T22:40:25+00:00", "published_display": "06 Oct 2026 22:40", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Kalkine"], "source_kind": "publisher", "story_key": "83fc26a5c134ce7fdd566f001aa50d1446c05d1a67ccb122f418638a2f0a36cb", "target_scope": "Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001978, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.4, "age_days": 9.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio (NASDAQ:BRVE) Stock Jumps 8.1% - Still a Buy?", "summary": "Braveheart Bio (NASDAQ: BRVE) shares rose 8.1% to $21.84, despite trading volume being 83% below average. Analysts generally have a positive outlook, with five \"Buy\" ratings and one \"Hold\" rating, and a consensus price target of $45.25. The company missed its quarterly earnings estimate significantly, reporting a loss of $2.51 per share against an estimated $0.25, but insiders have recently purchased a substantial amount of shares, totaling $157.5 million.", "url": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-stock-jumps-81-still-a-buy-2026-10-01", "source_link": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-stock-jumps-81-still-a-buy-2026-10-01", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-01T18:59:51", "published_display": "01 Oct 2026 18:59", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["BRVE", "BRVE.ARCHIVE"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "0426a602a116acb54fd72ef8bfff0c4d605e3acaa8d69094626991951fde9218", "target_scope": "Braveheart Bio (NASDAQ:BRVE) Stock Jumps 8.1% - Still a Buy? Braveheart Bio (NASDAQ: BRVE) shares rose 8.1% to $21.84, despite trading volume being 83% below average.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.7350000000000001, "provider_directional_mass": 0.1097, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 69, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001026, "evidence_share": 100.0, "evidence_share_display": "100", "freshness_pct": 0.6, "age_days": 14.9, "influence_label": "Medium", "evidence_strength": 47, "duplicate_count": 2, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Braveheart Bio, Inc. (NASDAQ:BRVE) Shares Shorted: Short Interest Up 76.1% in September", "summary": "Braveheart Bio, Inc. (NASDAQ:BRVE) experienced a significant surge in short interest in September, increasing by 76.1% to 2.46 million shares. This represents 2.7% of shares outstanding and a days-to-cover ratio of 7.5 days. Despite a recent quarterly EPS miss, insiders have been actively purchasing shares, acquiring over 8.75 million shares worth approximately $157.5 million in the last 90 days, and analysts maintain a \"Moderate Buy\" rating with an average price target of $45.25.", "url": "https://www.marketbeat.com/instant-alerts/options-braveheart-bio-inc-nasdaq-brve-shares-shorted-short-interest-up-761-in-september-2026-09-29", "source_link": "https://www.marketbeat.com/instant-alerts/options-braveheart-bio-inc-nasdaq-brve-shares-shorted-short-interest-up-761-in-september-2026-09-29", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-29T17:25:03", "published_display": "29 Sep 2026 17:25", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["BRVE", "BRVE.ARCHIVE"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "edeb405b875243fcefe785c4967339add31fbcdab0484f05d04629d47b37f605", "target_scope": "Braveheart Bio, Inc. (NASDAQ:BRVE) Shares Shorted: Short Interest Up 76.1% in September Braveheart Bio, Inc. (NASDAQ:BRVE) experienced a significant surge in short interest in September, increasing by 76.1% to 2.46 million shares.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.51, "provider_directional_mass": 0.1039, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00022, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.3, "age_days": 17.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "BRVE interactive stock chart | Braveheart Bio, Inc. stock", "summary": "This page provides an interactive stock chart for Braveheart Bio, Inc. (BRVE). The stock closed at $20.62, down 11.77%, and was trading at $21.08 in after-hours, up 2.21%. The chart allows users to select various time ranges and intervals to analyze the stock's performance.", "url": "https://uk.finance.yahoo.com/chart/BRVE", "source_link": "https://uk.finance.yahoo.com/chart/BRVE", "source_link_is_lookup": false, "source_name": "Market source", "published_at": "2026-09-25T10:51:06", "published_display": "25 Sep 2026 10:51", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["BRVE", "BRVE.ARCHIVE"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["Market source"], "source_kind": "aggregator", "story_key": "87cb69ff4a1727e7af0a17b81c989aaf75b418356b4685010d3cc0123546f53b", "target_scope": "BRVE interactive stock chart | Braveheart Bio, Inc. stock This page provides an interactive stock chart for Braveheart Bio, Inc. (BRVE).", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.3973, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 4.1e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 21.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio, Inc. (NASDAQ:BRVE) Receives Average Recommendation of \"Moderate Buy\" from Analysts", "summary": "Braveheart Bio, Inc. (NASDAQ:BRVE) has received an average \"Moderate Buy\" recommendation from analysts, with five out of six firms issuing a buy rating and an average 12-month price target of $45.25. Despite a significant earnings miss in the last quarter, insider buying has been substantial, with directors purchasing millions of shares totaling approximately $157.5 million. The company is a clinical-stage biopharmaceutical firm focused on therapies for hypertrophic cardiomyopathy, with its lead product candidate, BHB\u20111893, being developed for obstructive and non\u2011obstructive HCM.", "url": "https://www.marketbeat.com/instant-alerts/consensus-braveheart-bio-inc-nasdaq-brve-receives-average-recommendation-of-moderate-buy-from-analysts-2026-09-25", "source_link": "https://www.marketbeat.com/instant-alerts/consensus-braveheart-bio-inc-nasdaq-brve-receives-average-recommendation-of-moderate-buy-from-analysts-2026-09-25", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-25T09:54:30", "published_display": "25 Sep 2026 09:54", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["BRVE", "BRVE.ARCHIVE"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "3c94326537fc129a3c01c09577dc0466ef98594ac929557bd0831ed692227261", "target_scope": "Braveheart Bio, Inc. (NASDAQ:BRVE) Receives Average Recommendation of \"Moderate Buy\" from Analysts Braveheart Bio, Inc. (NASDAQ:BRVE) has received an average \"Moderate Buy\" recommendation from analysts, with five out of six firms issuing a buy rating and an average 12-month price target of $45.25.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.593, "provider_directional_mass": 0.1171, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 56, "tone_signals": ["Buy Rating"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000967, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.7, "age_days": 21.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio Inc (BRVE:UQ): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE56a09YenVKYUpqN1YtUTRFQ3JieVRaV0EyZXE1cmhvS1VYbzI2OU9DUUlCWXVYeG1fQk53cWRicTdNaXJ5WmljRE9EUWU3clFnb0lSMA?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE56a09YenVKYUpqN1YtUTRFQ3JieVRaV0EyZXE1cmhvS1VYbzI2OU9DUUlCWXVYeG1fQk53cWRicTdNaXJ5WmljRE9EUWU3clFnb0lSMA?oc=5", "source_link_is_lookup": false, "source_name": "bnnbloomberg.ca", "published_at": "2026-09-23T23:13:20+00:00", "published_display": "23 Sep 2026 23:13", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["BRVE.ARCHIVE"], "target_provider_symbol": "BRVE.ARCHIVE", "cross_listing": false, "source_names": ["BNN Bloomberg", "bnnbloomberg.ca", "kalkine.ca"], "source_kind": "editorial_wire", "story_key": "124066591c253f85d3ff0c3d5649ae16276f0c1d023083f50d441306e90b2016", "target_scope": "Braveheart Bio Inc (BRVE:UQ): Stock Price, Quote and News", "durable_archive": true, "archive_provider": "archive", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 3.8e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 22.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio (NASDAQ:BRVE) Hits New 52-Week Low - What's Next?", "summary": "Braveheart Bio (NASDAQ:BRVE) recently hit a new 52-week low of $24.17 after reporting significantly weaker-than-expected quarterly earnings. Despite the poor earnings performance, analysts maintain a \"Moderate Buy\" rating with an average price target of $45.25. Insider activity shows strong buying interest, with directors acquiring substantial shares in the last 90 days.", "url": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-hits-new-52-week-low-whats-next-2026-09-22", "source_link": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-hits-new-52-week-low-whats-next-2026-09-22", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-22T16:34:44", "published_display": "22 Sep 2026 16:34", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["AAPL", "AVGO", "BRVE", "BRVE.ARCHIVE", "MSFT", "NVDA"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["MarketBeat", "marketbeat.com"], "source_kind": "publisher", "story_key": "e9c817bc65fbc6c4227efa853f4f6e82d0490a606a7b400155c2d0663c765609", "target_scope": "Braveheart Bio (NASDAQ:BRVE) Hits New 52-Week Low - What's Next? Braveheart Bio (NASDAQ:BRVE) recently hit a new 52-week low of $24.17 after reporting significantly weaker-than-expected quarterly earnings.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.4274, "relevance_score": 1.0, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003023, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.6, "age_days": 24.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio (NASDAQ:BRVE) Trading Down 6.6% - Should You Sell?", "summary": "Braveheart Bio (NASDAQ:BRVE) shares dropped 6.6% to $27.26 on Monday, with trading volume significantly below average. Despite a substantial earnings miss, analysts maintain a \"Moderate Buy\" consensus with an average price target of $45.25. Insider buying totaling $157.5 million over the last three months suggests confidence in the company's future.", "url": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-trading-down-66-should-you-sell-2026-09-21", "source_link": "https://www.marketbeat.com/instant-alerts/price-braveheart-bio-nasdaq-brve-trading-down-66-should-you-sell-2026-09-21", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-21T16:46:25", "published_display": "21 Sep 2026 16:46", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["BRVE", "BRVE.ARCHIVE"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["MarketBeat", "marketbeat.com"], "source_kind": "publisher", "story_key": "f50cf4971e0cbfc427acda3dac4a48d534c9cc44c323228a8d31d77979a6e60c", "target_scope": "Braveheart Bio (NASDAQ:BRVE) Trading Down 6.6% - Should You Sell? Braveheart Bio (NASDAQ:BRVE) shares dropped 6.6% to $27.26 on Monday, with trading volume significantly below average.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.6839999999999999, "provider_directional_mass": 0.2982, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 44, "tone_signals": ["Negative market reaction", "Large negative market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.1e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 25.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Braveheart Bio to Participate in Stifel Cardiometabolic Forum", "summary": "Braveheart Bio, Inc. announced its participation in the Stifel Virtual Cardiometabolic Forum on September 30, 2026. Management will host a fireside chat at 12:30 p.m. EDT, which can be accessed via a live webcast on their investor relations website. The company is a clinical-stage biopharmaceutical firm focusing on treatments for hypertrophic cardiomyopathy and other cardiovascular diseases, with its lead candidate BHB-1893 targeting obstructive and non-obstructive HCM.", "url": "https://www.manilatimes.net/2026/09/17/tmt-newswire/globenewswire/braveheart-bio-to-participate-in-stifel-cardiometabolic-forum/2427012", "source_link": "https://www.manilatimes.net/2026/09/17/tmt-newswire/globenewswire/braveheart-bio-to-participate-in-stifel-cardiometabolic-forum/2427012", "source_link_is_lookup": false, "source_name": "The Manila Times", "published_at": "2026-09-16T20:58:16", "published_display": "16 Sep 2026 20:58", "provider": "alphavantage", "providers": ["alphavantage", "archive", "eodhd", "yfinance"], "provider_symbol": "BRVE.US", "provider_symbols": ["2891.TW", "BRVE", "BRVE.ARCHIVE", "BRVE.US", "SF", "SF.US"], "target_provider_symbol": "BRVE", "cross_listing": false, "source_names": ["GlobeNewswire", "The Manila Times", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "fac3a4e99c25ef6f72af2ae12f164acc712dbf33934abc150c568c44f821c6af", "target_scope": "Braveheart Bio to Participate in Stifel Cardiometabolic Forum Braveheart Bio, Inc. announced its participation in the Stifel Virtual Cardiometabolic Forum on September 30, 2026.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.2835, "relevance_score": 1.0, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 29.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 3, "topics": ["Biopharmaceuticals", "Cardiovascular", "Clinical Trials", "Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}], "industry": [], "sector": []}, "total_fetched": 12, "total_unique": 12, "total_relevant": 9, "pipeline_health": {"status": "healthy", "providers_attempted": 4, "providers_with_results": 4, "raw_articles": 59, "unique_stories": 38, "duplicates_removed": 21, "relevant_stories": 9, "matched_archive_stories": 17, "current_evidence": 1, "direct_evidence": 9, "archive_articles": 2, "durable_story_count": 12, "durable_evidence_used": true, "durable_collected_at": "2026-10-09T19:58:27.268494+00:00"}, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 8, "score": 50, "raw_score": 69, "total": 12, "evidence_count": 1, "effective_articles": 1.0, "information_mass": 0.001, "direct_story_count": 9, "directional_story_count": 1, "direct_source_count": 1, "industry_story_count": 0, "sector_story_count": 0, "story_count": 9, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 0, "confidence": 15, "evidence_status": "provisional", "score_version": "evidence-v11", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-10-06T22:40:25+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 4.55, "count": 7}, {"event": "analyst", "label": "Analyst action", "weight": 0.6, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.6, "count": 1}], "positive_events": 1, "negative_events": 0, "pipeline": {"status": "healthy", "providers_attempted": 4, "providers_with_results": 4, "raw_articles": 59, "unique_stories": 38, "duplicates_removed": 21, "relevant_stories": 9, "matched_archive_stories": 17, "current_evidence": 1, "direct_evidence": 9, "archive_articles": 2, "durable_story_count": 12, "durable_evidence_used": true, "durable_collected_at": "2026-10-09T19:58:27.268494+00:00"}}, "market_context": {"has_market_context": true, "latest_close": 20.02, "latest_week": "2026-10-09", "one_week_move": -5.9, "four_week_move": -24.8, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -22.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.3333, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.9% over one week, -24.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 15, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 5}, {"label": "Kalkine", "count": 1}, {"label": "Market source", "count": 1}, {"label": "bnnbloomberg.ca", "count": 1}, {"label": "The Manila Times", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Analyst action", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "15/100", "tone": "neutral", "text": "1.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "0/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.9% over one week, -24.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis"}], "updated_at": "2026-10-09T19:58:27.268494+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "9 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 50, "display": "50", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 15, "display": "15", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 100, "display": "100%", "tone": "positive", "note": "9 company stories"}, {"label": "Story agreement", "value": 100, "display": "100", "tone": "positive", "note": "0/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 0, "note": "0.001 after freshness weighting"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Company relevance", "value": 100, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 7, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 100, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 0, "note": "less reliance on one publisher"}], "influence": {"events": [{"label": "Market update", "positive": 0.001052, "negative": 0.0, "count": 1, "positive_share": 100.0, "positive_width": 50.0, "negative_share": 0.0, "negative_width": 0.0}], "sources": [{"label": "MarketBeat", "weight": 0.001052, "count": 1, "share": 100.0}], "directional_count": 1, "retained_count": 9, "source_count": 1, "top_share": 100.0, "axis_max": 100.0}, "freshness": 7, "source_independence": 0, "timeline": [{"date": "2026-09-17", "label": "17 Sep", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-18", "label": "18 Sep", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-19", "label": "19 Sep", "count": 0, "score": null, "tone": "neutral", "x": 105.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-20", "label": "20 Sep", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-21", "label": "21 Sep", "count": 1, "score": 44, "tone": "neutral", "x": 168.3, "y": 145.9, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-09-22", "label": "22 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-09-23", "label": "23 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-09-24", "label": "24 Sep", "count": 0, "score": null, "tone": "neutral", "x": 263.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-25", "label": "25 Sep", "count": 2, "score": 56, "tone": "neutral", "x": 294.7, "y": 124.1, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-09-26", "label": "26 Sep", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-27", "label": "27 Sep", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-28", "label": "28 Sep", "count": 0, "score": null, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-29", "label": "29 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-09-30", "label": "30 Sep", "count": 0, "score": null, "tone": "neutral", "x": 452.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-01", "label": "01 Oct", "count": 1, "score": 69, "tone": "positive", "x": 484.2, "y": 100.4, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-10-02", "label": "02 Oct", "count": 0, "score": null, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-03", "label": "03 Oct", "count": 0, "score": null, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-04", "label": "04 Oct", "count": 0, "score": null, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-05", "label": "05 Oct", "count": 0, "score": null, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-06", "label": "06 Oct", "count": 1, "score": 50, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-10-07", "label": "07 Oct", "count": 0, "score": null, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-08", "label": "08 Oct", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-09", "label": "09 Oct", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-10", "label": "10 Oct", "count": 0, "score": null, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-11", "label": "11 Oct", "count": 0, "score": null, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-12", "label": "12 Oct", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-13", "label": "13 Oct", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-14", "label": "14 Oct", "count": 0, "score": null, "tone": "neutral", "x": 894.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-15", "label": "15 Oct", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-16", "label": "16 Oct", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "168.3,145.9 199.9,135.0 231.5,135.0 294.7,124.1 421.0,135.0 484.2,100.4 642.1,135.0", "timeline_path": "M168.3,145.9 L199.9,135.0 L231.5,135.0 M294.7,124.1 M421.0,135.0 M484.2,100.4 M642.1,135.0", "timeline_has_signal": true, "timeline_start": "17 Sep", "timeline_mid": "02 Oct", "timeline_end": "16 Oct", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": null, "delta": null, "recent_count": 0, "prior_count": 0, "volume_delta": 0, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "No new story in 24 hours", "tone": "neutral", "latest_score": null, "baseline_score": null, "delta": null, "latest_count": 0, "baseline_count": 0, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 14 days", "count": 1, "share": 11}, {"label": "15 to 21 days", "count": 2, "share": 22}, {"label": "22 to 30 days", "count": 6, "share": 67}], "source_profile": [{"label": "MarketBeat", "count": 5, "share": 56, "score": 55, "tone": "neutral"}, {"label": "Kalkine", "count": 1, "share": 11, "score": 50, "tone": "neutral"}, {"label": "Market source", "count": 1, "share": 11, "score": 50, "tone": "neutral"}, {"label": "bnnbloomberg.ca", "count": 1, "share": 11, "score": 50, "tone": "neutral"}, {"label": "The Manila Times", "count": 1, "share": 11, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Market update", "count": 7, "share": 78, "score": 56, "tone": "neutral"}, {"label": "Analyst action", "count": 1, "share": 11, "score": 56, "tone": "neutral"}, {"label": "Earnings", "count": 1, "share": 11, "score": 50, "tone": "neutral"}], "topics": [{"label": "Life Sciences", "count": 7, "share": 78}, {"label": "Financial Markets", "count": 6, "share": 67}, {"label": "Earnings", "count": 5, "share": 56}, {"label": "Finance", "count": 3, "share": 33}, {"label": "Clinical Trials", "count": 1, "share": 11}, {"label": "Cardiovascular", "count": 1, "share": 11}, {"label": "Biopharmaceuticals", "count": 1, "share": 11}], "supporting": [{"label": "Direct evidence", "text": "9 current stories are mapped specifically to BRVE."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}, {"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.001."}, {"label": "Confidence", "text": "Confidence is 15/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1mUVFYUEJLUXV0eVJFVVliOEtqRnUwdXFEcG1GRmk2M1NFYVdfVF9nZnNRVFh0TVBzUDNHcDZUY2JJZTB3Q09sNkhrQTlERUhVcmU3VFhn?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1mUVFYUEJLUXV0eVJFVVliOEtqRnUwdXFEcG1GRmk2M1NFYVdfVF9nZnNRVFh0TVBzUDNHcDZUY2JJZTB3Q09sNkhrQTlERUhVcmU3VFhn?oc=5", "source_link_is_lookup": false, "source_name": "Kalkine", "published_at": "2026-10-06T22:40:25+00:00", "published_display": "06 Oct 2026 22:40", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002029, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.5, "age_days": 9.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, "article_count": 9, "updated_at": "2026-10-09T19:58:27.268494+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 55.8, "label": "07 Aug 2026", "close": 30.0, "index": 100.0}, {"x": 142.2, "y": 100.0, "label": "14 Aug 2026", "close": 27.03, "index": 90.1}, {"x": 242.4, "y": 91.8, "label": "21 Aug 2026", "close": 27.58, "index": 91.9}, {"x": 342.6, "y": 93.9, "label": "28 Aug 2026", "close": 27.44, "index": 91.5}, {"x": 442.8, "y": 104.3, "label": "04 Sep 2026", "close": 26.74, "index": 89.1}, {"x": 542.9, "y": 105.8, "label": "11 Sep 2026", "close": 26.64, "index": 88.8}, {"x": 643.1, "y": 67.7, "label": "18 Sep 2026", "close": 29.2, "index": 97.3}, {"x": 743.3, "y": 195.3, "label": "25 Sep 2026", "close": 20.62, "index": 68.7}, {"x": 843.5, "y": 185.6, "label": "02 Oct 2026", "close": 21.27, "index": 70.9}, {"x": 943.7, "y": 204.2, "label": "09 Oct 2026", "close": 20.02, "index": 66.7}], "sentiment_points": [{"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 59, "tone": "positive", "raw_score": 80, "confidence": 33, "stories": 14, "close": 30.0, "price_change": null, "x": 56.3, "y": 113.4, "show_label": true, "label_y": 103.4}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "label": "14 Aug 2026", "score": 51, "tone": "neutral", "raw_score": 72, "confidence": 18, "stories": 28, "close": 27.03, "price_change": -9.9, "x": 156.5, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 72, "confidence": 16, "stories": 31, "close": 27.58, "price_change": 2.0, "x": 256.7, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 72, "confidence": 16, "stories": 32, "close": 27.44, "price_change": -0.5, "x": 356.9, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 55, "tone": "neutral", "raw_score": 70, "confidence": 27, "stories": 38, "close": 26.74, "price_change": -2.6, "x": 457.1, "y": 120.8, "show_label": true, "label_y": 110.8}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 47, "tone": "neutral", "raw_score": 39, "confidence": 31, "stories": 29, "close": 26.64, "price_change": -0.4, "x": 557.2, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 53, "confidence": 25, "stories": 25, "close": 29.2, "price_change": 9.6, "x": 657.4, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 48, "tone": "neutral", "raw_score": 40, "confidence": 24, "stories": 29, "close": 20.62, "price_change": -29.4, "x": 757.6, "y": 133.7, "show_label": false, "label_y": 123.69999999999999}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 51, "tone": "neutral", "raw_score": 56, "confidence": 26, "stories": 23, "close": 21.27, "price_change": 3.2, "x": 857.8, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 50, "tone": "neutral", "raw_score": 56, "confidence": 17, "stories": 11, "close": 20.02, "price_change": -5.9, "x": 958.0, "y": 130.0, "show_label": true, "label_y": 120.0}], "price_path": "42.0,55.8 142.2,100.0 242.4,91.8 342.6,93.9 442.8,104.3 542.9,105.8 643.1,67.7 743.3,195.3 843.5,185.6 943.7,204.2", "sentiment_path": "56.3,113.4 156.5,128.2 256.7,130.0 356.9,130.0 457.1,120.8 557.2,135.5 657.4,128.2 757.6,133.7 857.8,128.2 958.0,130.0", "score_version": "evidence-v11", "price_change": -33.3, "sentiment_change": -9, "recent_pairs": [{"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 50, "tone": "neutral", "raw_score": 56, "confidence": 17, "stories": 11, "close": 20.02, "price_change": -5.9, "x": 958.0, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 51, "tone": "neutral", "raw_score": 56, "confidence": 26, "stories": 23, "close": 21.27, "price_change": 3.2, "x": 857.8, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 48, "tone": "neutral", "raw_score": 40, "confidence": 24, "stories": 29, "close": 20.62, "price_change": -29.4, "x": 757.6, "y": 133.7, "show_label": false, "label_y": 123.69999999999999}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 53, "confidence": 25, "stories": 25, "close": 29.2, "price_change": 9.6, "x": 657.4, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 47, "tone": "neutral", "raw_score": 39, "confidence": 31, "stories": 29, "close": 26.64, "price_change": -0.4, "x": 557.2, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 55, "tone": "neutral", "raw_score": 70, "confidence": 27, "stories": 38, "close": 26.74, "price_change": -2.6, "x": 457.1, "y": 120.8, "show_label": true, "label_y": 110.8}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 72, "confidence": 16, "stories": 32, "close": 27.44, "price_change": -0.5, "x": 356.9, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 72, "confidence": 16, "stories": 31, "close": 27.58, "price_change": 2.0, "x": 256.7, "y": 130.0, "show_label": true, "label_y": 120.0}], "reconstructed": true, "latest_close": 20.02, "price_observations": 10, "sentiment_observations": 10, "sentiment_start_label": "07 Aug 2026", "sentiment_end_label": "09 Oct 2026", "sentiment_history_limited": false, "price_axis_high": 104.0, "price_axis_mid": 83.4, "price_axis_low": 62.7, "start_label": "07 Aug", "mid_label": "08 Sep", "end_label": "09 Oct", "live_score_version": "evidence-v11", "comparable_to_live": true}, "sentiment_history": [{"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "positive", "height": 18, "articles": 14, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 2, "tone": "neutral", "height": 14, "articles": 16, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": -3, "score_change_display": "-3", "confidence_change": -2, "article_change": 6, "tone": "neutral", "height": 8, "articles": 22, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 6, "articles": 24, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 4, "tone": "neutral", "height": 4, "articles": 28, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 30, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "19 Aug 23:59", "short_label": "19 Aug", "collected_at": "2026-08-19T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 31, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 32, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "31 Aug 23:59", "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 9, "score_change_display": "+9", "confidence_change": 25, "article_change": 4, "tone": "positive", "height": 18, "articles": 36, "confidence": 41, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 3, "tone": "positive", "height": 16, "articles": 39, "confidence": 38, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "08 Sep 23:59", "short_label": "08 Sep", "collected_at": "2026-09-08T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": -12, "score_change_display": "-12", "confidence_change": -1, "article_change": -8, "tone": "neutral", "height": 8, "articles": 31, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 8, "articles": 31, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Sep 23:59", "short_label": "14 Sep", "collected_at": "2026-09-14T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 1, "score_change_display": "+1", "confidence_change": -9, "article_change": -5, "tone": "neutral", "height": 6, "articles": 26, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "15 Sep 23:59", "short_label": "15 Sep", "collected_at": "2026-09-15T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 5, "score_change_display": "+5", "confidence_change": 6, "article_change": 1, "tone": "neutral", "height": 4, "articles": 27, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "16 Sep 23:59", "short_label": "16 Sep", "collected_at": "2026-09-16T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 28, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "21 Sep 23:59", "short_label": "21 Sep", "collected_at": "2026-09-21T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -3, "score_change_display": "-3", "confidence_change": 0, "article_change": -2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Sep 23:59", "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 26, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 27, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 4, "articles": 29, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 1, "score_change_display": "+1", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 30, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": 9, "article_change": -7, "tone": "neutral", "height": 4, "articles": 23, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Oct 23:59", "short_label": "06 Oct", "collected_at": "2026-10-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -10, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 19, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "16 Oct 15:40", "short_label": "16 Oct", "collected_at": "2026-10-16T15:40:43.581653+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -15, "tone": "neutral", "height": 4, "articles": 9, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v11", "live_version": "evidence-v11", "comparable_to_live": true, "reconstructed": true, "observations": 23, "span_label": "70 days", "first_score": 59, "latest_score": 50, "net_change": -9, "net_change_display": "-9", "direction": "Weakening", "high_score": 59, "low_score": 46, "latest_confidence": 16, "confidence_change": -17, "latest_articles": 9, "article_change": -5, "latest_label": "16 Oct 15:40", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "positive", "height": 18, "articles": 14, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 42.0, "y": 118.6}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 2, "tone": "neutral", "height": 14, "articles": 16, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 83.6, "y": 122.3}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": -3, "score_change_display": "-3", "confidence_change": -2, "article_change": 6, "tone": "neutral", "height": 8, "articles": 22, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 125.3, "y": 127.7}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 6, "articles": 24, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 166.9, "y": 129.5}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 4, "tone": "neutral", "height": 4, "articles": 28, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 208.5, "y": 133.2}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 30, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 250.2, "y": 135.0}, {"label": "19 Aug 23:59", "short_label": "19 Aug", "collected_at": "2026-08-19T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 31, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 291.8, "y": 135.0}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 32, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 333.5, "y": 135.0}, {"label": "31 Aug 23:59", "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 9, "score_change_display": "+9", "confidence_change": 25, "article_change": 4, "tone": "positive", "height": 18, "articles": 36, "confidence": 41, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 375.1, "y": 118.6}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 3, "tone": "positive", "height": 16, "articles": 39, "confidence": 38, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 416.7, "y": 120.4}, {"label": "08 Sep 23:59", "short_label": "08 Sep", "collected_at": "2026-09-08T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": -12, "score_change_display": "-12", "confidence_change": -1, "article_change": -8, "tone": "neutral", "height": 8, "articles": 31, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 458.4, "y": 142.3}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 8, "articles": 31, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 500.0, "y": 142.3}, {"label": "14 Sep 23:59", "short_label": "14 Sep", "collected_at": "2026-09-14T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 1, "score_change_display": "+1", "confidence_change": -9, "article_change": -5, "tone": "neutral", "height": 6, "articles": 26, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 541.6, "y": 140.5}, {"label": "15 Sep 23:59", "short_label": "15 Sep", "collected_at": "2026-09-15T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 5, "score_change_display": "+5", "confidence_change": 6, "article_change": 1, "tone": "neutral", "height": 4, "articles": 27, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 583.3, "y": 131.4}, {"label": "16 Sep 23:59", "short_label": "16 Sep", "collected_at": "2026-09-16T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 28, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 624.9, "y": 133.2}, {"label": "21 Sep 23:59", "short_label": "21 Sep", "collected_at": "2026-09-21T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -3, "score_change_display": "-3", "confidence_change": 0, "article_change": -2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 666.5, "y": 138.6}, {"label": "22 Sep 23:59", "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 26, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 708.2, "y": 138.6}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 27, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 749.8, "y": 138.6}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 4, "articles": 29, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 791.5, "y": 138.6}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 1, "score_change_display": "+1", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 30, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 833.1, "y": 136.8}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": 9, "article_change": -7, "tone": "neutral", "height": 4, "articles": 23, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 874.7, "y": 133.2}, {"label": "06 Oct 23:59", "short_label": "06 Oct", "collected_at": "2026-10-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -10, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 19, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 916.4, "y": 135.0}, {"label": "16 Oct 15:40", "short_label": "16 Oct", "collected_at": "2026-10-16T15:40:43.581653+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -15, "tone": "neutral", "height": 4, "articles": 9, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 958.0, "y": 135.0}], "chart_points": "42.0,118.6 83.6,122.3 125.3,127.7 166.9,129.5 208.5,133.2 250.2,135.0 291.8,135.0 333.5,135.0 375.1,118.6 416.7,120.4 458.4,142.3 500.0,142.3 541.6,140.5 583.3,131.4 624.9,133.2 666.5,138.6 708.2,138.6 749.8,138.6 791.5,138.6 833.1,136.8 874.7,133.2 916.4,135.0 958.0,135.0", "changes": [{"label": "16 Oct 15:40", "short_label": "16 Oct", "collected_at": "2026-10-16T15:40:43.581653+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -15, "tone": "neutral", "height": 4, "articles": 9, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Oct 23:59", "short_label": "06 Oct", "collected_at": "2026-10-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -10, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 19, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": 9, "article_change": -7, "tone": "neutral", "height": 4, "articles": 23, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 1, "score_change_display": "+1", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 30, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 4, "articles": 29, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 27, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Sep 23:59", "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 26, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "21 Sep 23:59", "short_label": "21 Sep", "collected_at": "2026-09-21T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -3, "score_change_display": "-3", "confidence_change": 0, "article_change": -2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}